The CFO of Valox, a brokerage firm and SEC registrant ("Valox" or the "Company"), is contemplating a sale of one of its reporting units, Geneva ("Geneva" or the "Subsidiary"), a wholly owned subsidiary of the Company located in the Midwest. California law allows the Company to include Geneva in its combined group for California state income tax purposes. Therefore, Geneva's receipts are currently included in the Company's calculation of its California sales apportionment factor. Geneva has very few, if any, California customers and therefore the inclusion of Geneva's activity in the receipts factor significantly dilutes the Company's California resulting apportionment percentage. If the Company sells Geneva, the California state apportionment factor will increase significantly (from 1% currently to approximately 14% post-sale) since Valox's total revenues will no longer include Geneva's revenues outside the state of California. The increase in the state apportionment factor will result in a higher effective California state income tax rate for the Company The Company's existing California future deductible amounts from temporary differences are expected to be recovered over the next five years and they will not be reduced or otherwise affected by the sale of Geneva. Therefore, the Company will still be able to utilize the deferred tax assets (DTA) related to Geneva in its California returns subsequent to the sale of Geneva. The Board of Directors is expected to vote on the sale of Geneva prior to June 30, 2020 (the Company's fiscal year end). If the Board approves the sale of Geneva, the subsidiary will be classified as held-for-sale as of June 30, 2020, Required: Assuming the Board approves the sale of Geneva and that Geneva meets the criteria in ASC 360-10-45-9, Plant, Property, and Equipment Overall, to be classified as held-for-sale as of June 30, 2020, address the following issue: When measuring Valox's existing deferred tax assets at June 30, 2020, should Valox use its current California apportionment factor, which includes Geneva's receipts, or its anticipated California apportionment factor reflecting the sale of Geneva